Full text is available at the source.
Abstract
Diminished Ovarian Reserve (DOR) is associated with significant impacts on fertility and quality of life.
- Key molecular events linked to DOR include telomere shortening, mitochondrial dysfunction, and epigenetic changes.
- Current clinical diagnostic criteria and emerging biomarkers for DOR are summarized.
- Limitations of existing treatment strategies for DOR are examined.
- Potential interventions based on aging reprogramming are discussed.
Simplified